704 related articles for article (PubMed ID: 10851026)
1. Signaling by fibroblast growth factors (FGF) and fibroblast growth factor receptor 2 (FGFR2)-activating mutations blocks mineralization and induces apoptosis in osteoblasts.
Mansukhani A; Bellosta P; Sahni M; Basilico C
J Cell Biol; 2000 Jun; 149(6):1297-308. PubMed ID: 10851026
[TBL] [Abstract][Full Text] [Related]
2. Activating (P253R, C278F) and dominant negative mutations of FGFR2: differential effects on calvarial bone cell proliferation, differentiation, and mineralization.
Ratisoontorn C; Fan GF; McEntee K; Nah HD
Connect Tissue Res; 2003; 44 Suppl 1():292-7. PubMed ID: 12952211
[TBL] [Abstract][Full Text] [Related]
3. Sox2 induction by FGF and FGFR2 activating mutations inhibits Wnt signaling and osteoblast differentiation.
Mansukhani A; Ambrosetti D; Holmes G; Cornivelli L; Basilico C
J Cell Biol; 2005 Mar; 168(7):1065-76. PubMed ID: 15781477
[TBL] [Abstract][Full Text] [Related]
4. A soluble form of fibroblast growth factor receptor 2 (FGFR2) with S252W mutation acts as an efficient inhibitor for the enhanced osteoblastic differentiation caused by FGFR2 activation in Apert syndrome.
Tanimoto Y; Yokozeki M; Hiura K; Matsumoto K; Nakanishi H; Matsumoto T; Marie PJ; Moriyama K
J Biol Chem; 2004 Oct; 279(44):45926-34. PubMed ID: 15310757
[TBL] [Abstract][Full Text] [Related]
5. Dura in the pathogenesis of syndromic craniosynostosis: fibroblast growth factor receptor 2 mutations in dural cells promote osteogenic proliferation and differentiation of osteoblasts.
Ang BU; Spivak RM; Nah HD; Kirschner RE
J Craniofac Surg; 2010 Mar; 21(2):462-7. PubMed ID: 20489451
[TBL] [Abstract][Full Text] [Related]
6. The Ser252Trp fibroblast growth factor receptor-2 (FGFR-2) mutation induces PKC-independent downregulation of FGFR-2 associated with premature calvaria osteoblast differentiation.
Lemonnier J; Delannoy P; Hott M; Lomri A; Modrowski D; Marie PJ
Exp Cell Res; 2000 Apr; 256(1):158-67. PubMed ID: 10739663
[TBL] [Abstract][Full Text] [Related]
7. Role of N-cadherin and protein kinase C in osteoblast gene activation induced by the S252W fibroblast growth factor receptor 2 mutation in Apert craniosynostosis.
Lemonnier J; Haÿ E; Delannoy P; Lomri A; Modrowski D; Caverzasio J; Marie PJ
J Bone Miner Res; 2001 May; 16(5):832-45. PubMed ID: 11341328
[TBL] [Abstract][Full Text] [Related]
8. Increased calvaria cell differentiation and bone matrix formation induced by fibroblast growth factor receptor 2 mutations in Apert syndrome.
Lomri A; Lemonnier J; Hott M; de Parseval N; Lajeunie E; Munnich A; Renier D; Marie PJ
J Clin Invest; 1998 Mar; 101(6):1310-7. PubMed ID: 9502772
[TBL] [Abstract][Full Text] [Related]
9. Apert syndrome mutant FGFR2 and its soluble form reciprocally alter osteogenesis of primary calvarial osteoblasts.
Suzuki H; Suda N; Shiga M; Kobayashi Y; Nakamura M; Iseki S; Moriyama K
J Cell Physiol; 2012 Sep; 227(9):3267-77. PubMed ID: 22105374
[TBL] [Abstract][Full Text] [Related]
10. The effects of fibroblast growth factor-2 on human neonatal calvaria osteoblastic cells are differentiation stage specific.
Debiais F; Hott M; Graulet AM; Marie PJ
J Bone Miner Res; 1998 Apr; 13(4):645-54. PubMed ID: 9556064
[TBL] [Abstract][Full Text] [Related]
11. Regulation of human cranial osteoblast phenotype by FGF-2, FGFR-2 and BMP-2 signaling.
Marie PJ; Debiais F; Haÿ E
Histol Histopathol; 2002; 17(3):877-85. PubMed ID: 12168799
[TBL] [Abstract][Full Text] [Related]
12. Increased expression of protein kinase Calpha, interleukin-1alpha, and RhoA guanosine 5'-triphosphatase in osteoblasts expressing the Ser252Trp fibroblast growth factor 2 receptor Apert mutation: identification by analysis of complementary DNA microarray.
Lomri A; Lemonnier J; Delannoy P; Marie PJ
J Bone Miner Res; 2001 Apr; 16(4):705-12. PubMed ID: 11315998
[TBL] [Abstract][Full Text] [Related]
13. FGF2 alters expression of the pyrophosphate/phosphate regulating proteins, PC-1, ANK and TNAP, in the calvarial osteoblastic cell line, MC3T3E1(C4).
Hatch NE; Nociti F; Swanson E; Bothwell M; Somerman M
Connect Tissue Res; 2005; 46(4-5):184-92. PubMed ID: 16546821
[TBL] [Abstract][Full Text] [Related]
14. P253R fibroblast growth factor receptor-2 mutation induces RUNX2 transcript variants and calvarial osteoblast differentiation.
Baroni T; Carinci P; Lilli C; Bellucci C; Aisa MC; Scapoli L; Volinia S; Carinci F; Pezzetti F; Calvitti M; Farina A; Conte C; Bodo M
J Cell Physiol; 2005 Feb; 202(2):524-35. PubMed ID: 15389579
[TBL] [Abstract][Full Text] [Related]
15. Cbl-mediated degradation of Lyn and Fyn induced by constitutive fibroblast growth factor receptor-2 activation supports osteoblast differentiation.
Kaabeche K; Lemonnier J; Le Mée S; Caverzasio J; Marie PJ
J Biol Chem; 2004 Aug; 279(35):36259-67. PubMed ID: 15190072
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic effect of nanogel-based delivery of soluble FGFR2 with S252W mutation on craniosynostosis.
Yokota M; Kobayashi Y; Morita J; Suzuki H; Hashimoto Y; Sasaki Y; Akiyoshi K; Moriyama K
PLoS One; 2014; 9(7):e101693. PubMed ID: 25003957
[TBL] [Abstract][Full Text] [Related]
17. Contribution of Src and Ras pathways in FGF-2 induced endothelial cell differentiation.
Klint P; Kanda S; Kloog Y; Claesson-Welsh L
Oncogene; 1999 Jun; 18(22):3354-64. PubMed ID: 10362356
[TBL] [Abstract][Full Text] [Related]
18. A Ser252Trp [corrected] substitution in mouse fibroblast growth factor receptor 2 (Fgfr2) results in craniosynostosis.
Chen L; Li D; Li C; Engel A; Deng CX
Bone; 2003 Aug; 33(2):169-78. PubMed ID: 14499350
[TBL] [Abstract][Full Text] [Related]
19. Increased osteoblast apoptosis in apert craniosynostosis: role of protein kinase C and interleukin-1.
Lemonnier J; Haÿ E; Delannoy P; Fromigué O; Lomri A; Modrowski D; Marie PJ
Am J Pathol; 2001 May; 158(5):1833-42. PubMed ID: 11337381
[TBL] [Abstract][Full Text] [Related]
20. Role of fibroblast growth factor receptors (FGFR) and FGFR like-1 (FGFRL1) in mesenchymal stromal cell differentiation to osteoblasts and adipocytes.
Kähkönen TE; Ivaska KK; Jiang M; Büki KG; Väänänen HK; Härkönen PL
Mol Cell Endocrinol; 2018 Feb; 461():194-204. PubMed ID: 28923346
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
